| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | QNST | United States | $15.28 | $282,140,000.00 | Buy | 4 | 2009 |
#2 | TBLA | United States | $3.58 | $1,912,040,000.00 | Strong Buy | 4 | 2021 |
#3 | FLYW | United States | $17.24 | $623,025,000.00 | Buy | 14 | 2021 |
#4 | PRMB | United States | $19.64 | $6,664,000,000.00 | Buy | 9 | 2025 |
#5 | EVER | United States | $19.35 | $163,349,000.00 | Strong Buy | 5 | 2018 |
#6 | ZVRA | United States | $11.58 | $106,470,000.00 | Strong Buy | 5 | 2015 |
#7 | BXMT | United States | $13.14 | $0.00 | Buy | 5 | 1998 |
#8 | NTST | United States | $18.31 | $195,006,000.00 | Strong Buy | 14 | 2020 |
#9 | NMRK | United States | $13.94 | $3,294,024,000.00 | Buy | 5 | 2017 |
#10 | ALHC | United States | $7.99 | $3,948,719,000.00 | Buy | 8 | 2021 |
#11 | BBOT | United States | $4.66 | $0.00 | Strong Buy | 7 | 2024 |
#12 | SI | United States | $17.61 | $47,317,000.00 | Strong Buy | 5 | 2025 |
#13 | PTEN | United States | $11.14 | $4,826,624,000.00 | Buy | 10 | 1995 |
#14 | MPLT | United States | $10.86 | $0.00 | Strong Buy | 7 | 2025 |
#15 | KLRS | United States | $3.24 | $165,000.00 | Strong Buy | 4 | 2020 |
#16 | EVMN | United States | $9.60 | $13,000,000.00 | Strong Buy | 10 | 2025 |
#17 | CALY | United States | $14.81 | $2,060,100,000.00 | Buy | 4 | 1994 |
#18 | AVTX | United States | $16.51 | $27,813,137.00 | Strong Buy | 8 | 2015 |
#19 | NRXP | United States | $3.22 | $1,225,000.00 | Strong Buy | 4 | 2017 |
#20 | ACRS | United States | $5.72 | $1,683,000.00 | Strong Buy | 5 | 2015 |
#21 | BIOA | United States | $8.46 | $8,995,000.00 | Strong Buy | 6 | 2024 |
#22 | PRVA | United States | $19.49 | $2,122,842,000.00 | Buy | 12 | 2021 |
#23 | ARRY | United States | $3.96 | $1,284,141,000.00 | Buy | 19 | 2020 |
#24 | AGNC | United States | $10.08 | $0.00 | Buy | 13 | 2008 |
#25 | STTK | United States | $6.50 | $1,000,000.00 | Buy | 7 | 2020 |
#26 | VLY | United States | $13.12 | $0.00 | Strong Buy | 13 | 1994 |
#27 | MAMA | United States | $13.80 | $95,420,129.00 | Strong Buy | 5 | 2011 |
#28 | INGN | United States | $5.23 | $348,668,000.00 | Strong Buy | 4 | 2013 |
#29 | PHAT | United States | $7.76 | $175,110,000.00 | Strong Buy | 6 | 2019 |
#30 | EVLV | United States | $4.93 | $145,905,000.00 | Strong Buy | 4 | 2020 |
#31 | IRT | United States | $14.76 | $657,696,000.00 | Buy | 10 | 2009 |
#32 | ENVX | United States | $3.06 | $31,821,000.00 | Buy | 9 | 2020 |
#33 | KVUE | United States | $17.89 | $15,124,000,000.00 | Buy | 11 | 2023 |
#34 | LXEO | United States | $4.07 | $654,000.00 | Strong Buy | 9 | 2023 |
#35 | CRTO | France | $16.85 | $2,296,692,000.00 | Strong Buy | 10 | 2013 |
#36 | IMUX | United States | $10.84 | $0.00 | Strong Buy | 6 | 2013 |
#37 | ERAS | United States | $15.55 | $0.00 | Strong Buy | 12 | 2021 |
#38 | MGTX | United States | $12.35 | $81,391,000.00 | Strong Buy | 7 | 2018 |
#39 | TRVI | United States | $15.24 | $0.00 | Strong Buy | 11 | 2019 |
#40 | RLAY | United States | $19.35 | $15,355,000.00 | Strong Buy | 10 | 2020 |
#41 | TLS | United States | $4.10 | $164,805,000.00 | Buy | 5 | 2020 |
#42 | ENTA | United States | $12.42 | $102,814,000.00 | Strong Buy | 5 | 2012 |
#43 | MAX | United States | $9.98 | $1,113,600,000.00 | Buy | 5 | 2020 |
#44 | FHTX | United States | $4.24 | $30,909,000.00 | Strong Buy | 8 | 2020 |
#45 | FNB | United States | $17.62 | $0.00 | Strong Buy | 5 | 2002 |
#46 | SBRA | United States | $19.81 | $774,632,000.00 | Buy | 8 | 2010 |
#47 | RGNX | United States | $8.15 | $10,393,000.00 | Strong Buy | 8 | 2015 |
#48 | ZNTL | United States | $3.08 | $0.00 | Buy | 5 | 2020 |
#49 | NWBI | United States | $15.21 | $0.00 | Buy | 4 | 2009 |
#50 | CCCC | United States | $3.31 | $35,947,000.00 | Strong Buy | 6 | 2020 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $20 to Buy (September 23, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.